Integrating structure and function of 'tandem-repeat' galectins

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 3, 2012, Pages 864-887

  Troncoso, Maria F ^a   Elola, Maria T ^a   Croci, Diego O ^b   Rabinovich, Gabriel A ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Autoimmunity; Cancer; Galectins; Inflammation; Review; Tandem repeat

Indexed keywords

ECALECTIN; GALECTIN; GALECTIN 12; GALECTIN 4; GALECTIN 6; GALECTIN 8; UNCLASSIFIED DRUG; BETA GALACTOSIDE; BETA-GALACTOSIDE; GALACTOSIDE; LIGAND;

ADIPOCYTE; ARTICLE; AUTOIMMUNITY; ENTERITIS; HUMAN; INFLAMMATION; LUPUS ERYTHEMATOSUS; NEUTROPHIL; NONHUMAN; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TANDEM REPEAT; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CONSERVED SEQUENCE; GALACTOSIDES; GALECTINS; HUMANS; LIGANDS; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TANDEM REPEAT SEQUENCES;

EID: 84869390769     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (186)

1. R. Y. Yang, G. A. Rabinovich, F. T. Liu: Galectins: structure, function and therapeutic potential. Expert Rev Mol. Med. 10, e17 (2008)
2. F. T. Liu, G. A. Rabinovich: Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci 1183, 158-182 (2010)
3. Y. Levy, S. Auslender, M. Eisenstein, R. R. Vidavski, D. Ronen, A. D. Bershadsky, Y. Zick: It depends on the hinge: a structure-functional analysis of galectin-8, a tandemrepeat type lectin. Glycobiology 16, 463-476 (2006) (Pubitemid 43779043)
4. Y. Kashio, K. Nakamura, M. J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, M. Hirashima: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170, 3631-3636 (2003) (Pubitemid 36359232)
5. S. Bi, L. A. Earl, L. Jacobs, L. G. Baum: Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J Biol Chem 283, 12248-12258 (2008)
6. B. N. Stillman, D. K. Hsu, M. Pang, C. F. Brewer, P. Johnson, F. T. Liu, L. G. Baum: Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176, 778-789 (2006) (Pubitemid 43099674)
7. S. R Stowell, S. Karmakar, C. J. Stowell, M. Dias-Baruffi, R. P. McEver, R. D. Cummings: Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 109, 219-227 (2007) (Pubitemid 46053062)
8. S. R. Stowell, C. M. Arthur, K. A. Slanina, J. R. Horton, D. F. Smith, R. D. Cummings: Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. J Biol Chem 283, 20547-20559 (2008)
9. S. R. Stowell, Y. Qian, S. Karmakar, N. S. Koyama, M. Dias-Baruffi, H. Leffler, R. P. McEver, R. D. Cummings: Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J Immunol 180, 3091-3102 (2008)
10. L. A. Earl, S. Bi, L. G. Baum: Galectin multimerization and lattice formation are regulated by linker region structure. Glycobiology 21, 6-12 (2011)
11. M. T. Elola, C. Wolfenstein-Todel, M. F. Troncoso, G. R. Vasta, G. A. Rabinovich: Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 64, 1679-1700 (2007) (Pubitemid 47036942)
12. L. V. Norling, M. Perretti, D. Cooper: Endogenous galectins and the control of the host inflammatory response. J Endocrinol 201, 169-184 (2009)
13. G. A. Rabinovich: Galectin-1 as a potential cancer target. Br J Cancer 92(7), 1188-1192 (2005) (Pubitemid 40604390)
14. S. R. Stowell, C. M. Arthur, M. Dias-Baruffi, L. C. Rodrigues, J. P. Gourdine, J. Heimburg-Molinaro, T. Ju, R. J. Molinaro, C. Rivera-Marrero, B. Xia, D. F. Smith, R. D. Cummings: Innate immune lectins kill bacteria expressing blood group antigen. Nat Med 16(3), 295-301 (2010)
15. F. T. Liu, C. L. Bevins: A sweet target for innate immunity. Nat Med 16(3), 263-264 (2010)
16. A. Danguy, I. Camby, R. Kiss: Galectins and cancer. Biochim Biophys Acta 1572, 285-293 (2002) (Pubitemid 35246351)
17. F. van den Brule, S. Califice, V. Castronovo: Expression of galectins in cancer: a critical review. Glycoconj J 19(7-9), 537-542 (2004)
18. H. Lahm, S. Andre, A. Hoeflich, H. Kaltner, H. C. Siebert, B. Sordat, C. W. von der Lieth, E. Wolf, H. J. Gabius: Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J 20, 227-238 (2004) (Pubitemid 39090669)
19. Y. Takenaka, T. Fukumori, A. Raz: Galectin-3 and metastasis. Glycoconj J 19, 543-549 (2004) (Pubitemid 38316528)
20. H. Ahmed, F. Cappello, V. Rodolico, G. R. Vasta: Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer. Trans Oncol 2(3), 146-156 (2009)
21. F. T. Liu, G. A. Rabinovich: Galectins as modulators of tumour progression. Nat Rev Cancer 5, 29-41 (2005) (Pubitemid 40052323)
22. J. Ellerhorst, T. Nguyen, D. N. Cooper, D. Lotan, R. Lotan: Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol 14, 217-224 (1999)
23. Y. Levy, R. Arbel-Goren, Y. R. Hadari, S. Eshhar, D. Ronen, E. Elhanany, B. Geiger, Y. Zick: Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 276, 31285-31295 (2001) (Pubitemid 37384999)
24. F. van den Brüle, S. Califice, F. Garnier, P. L. Fernandez, A. Berchuk, V. Castronovo: Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 83, 377-386 (2003) (Pubitemid 36350999)
25. N. Tinari, I. Kuwabara, M. E Hufflejt, P. F. Shen, S. Iacobelli, F. T. Liu: Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 91, 167-172 (2001) (Pubitemid 32041735)
26. V. V. Glinsky, G. V. Glinsky, O. V. Glinskii, V. H. Huxley, J. R. Turk, V. V. Mossine, S. L. Deutscher, K. J. Pienta, T. P. Quinn: Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 63, 3805-3811 (2003) (Pubitemid 36793070)
27. N. LeMarer, R. C. Hughes: Effects of the carbohydratebinding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 168, 51-58 (1996) (Pubitemid 26233432)
28. A. Hittelet, H. Legendre, N. Nagy, Y. Bronckart, J. C. Pector, I. Salmon, P. Yeaton, H. J. Gabius, R. Kiss, I. Camby: Up-regulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103, 370-379 (2003) (Pubitemid 36076430)
29. N. Clausse, F. van den Brüle, D. Waltregny, F. Garnier, V. Castronovo: Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3, 317-325 (1999) (Pubitemid 129643974)
30. P. Nangia-Makker, Y. Honjo, R. Sarvis, S. Akahani, V. Hogan, K. J. Pienta, A. Raz: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156, 899-909 (2000) (Pubitemid 30626949)
31. V. L. J. L. Thijssen, R. Postel, R. J. M. G. E. Brandwijk, R. P. M. Dings, Y. Nesmelova, S. Satijn, N. Verhofstad, Y. Nakabeppu, L. G. Baum, J. Bakkers, K. H. Mayo, F. Poirier, A. W. Griffioen: Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Nat Acad Sci USA 103, 15975-15980 (2006) (Pubitemid 44657577)
32. V. L. Thijssen, S. Hulsmans, A. W. Griffioen: The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol 172, 545-553 (2008) (Pubitemid 351282039)
33. V. M. Cárdenas Delgado, L. G. Nugnes, L. L. Colombo, M. F. Troncoso, M. M. Fernández, E. L. Malchiodi, I. Frahm, D. O. Croci, D. Compagno, G. A. Rabinovich, C. Wolfenstein-Todel, M. T. Elola: Modulation of endothelial cell migration and angiogenesis: a novel function for the 'tandem-repeat' lectin galectin-8. FASEB J 25, 242-254 (2011)
34. N. Rubinstein, M. Alvarez, N. W. Zwirner, M. A. Toscano, J. M. Ilarregui, A. Bravo, J. Mordoh, L Fainboim. O. L. Podhajcer, G. A. Rabinovich: Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T-cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell 5, 241-251 (2004) (Pubitemid 38402116)
35. Q. T. Le, G. Shi, H. Cao, D. W. Nelson, Y. Wang, E. Y. Chen, S. Zhao, C. Kong, D. Richardson, K. J. O'Byrne, A. J. Giaccia, A. C. Koong: Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23, 8932-8941 (2005) (Pubitemid 46211478)
36. M. Salatino, G. A. Rabinovich: Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview. Methods Mol Biol 677, 355-374 (2011)
37. Y. Honjo, P. Nangia-Makker, H. Inohara, A. Raz: Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7, 661-668 (2001) (Pubitemid 32707992)
38. H. Inufusa, M. Nakamura, T. Adachi, M. Aga, M. Kurimoto, Y. Nakatani, T. Wakano, M., Miyake. K. Okuno, H. Shiozaki, M. Yasutomi: Role of galectin-3 in adenocarcinoma liver metastasis. Int J Oncol 19, 913-919 (2001)
39. I. Camby, N. Belot, F. Lefranc, N. Sadeghi, Y. de Launoit, H. Kaltner, S. Musette, F. Darro, A. Danguy, I. Salmon, H. J. Gabius, R. Kiss: Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J Neuropathol Exp Neurol 61, 585-596 (2002) (Pubitemid 34721463)
40. Y. K. Song, T. R. Billiar, Y. J. Lee: Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 160, 1069-1075 (2002) (Pubitemid 34224593)
41. C. M. John, H. Leffler, B. Kahl-Knutsson, I. Svensson, G. A. Jarvis: Truncated galectin-3 inhibits tumor growth and metastasis in orthopic nude mouse model of human breast cancer. Clin Cancer Res 9, 2374-2383 (2003) (Pubitemid 36687665)
42. S. Califice, V. Castronovo, M. Bracke, F. van den Brüle: Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23, 7527-7536 (2004) (Pubitemid 39389694)
43. S. Ueda, I. Kuwabara, F. T. Liu: Suppression of tumor growth by galectin-7 gene transfer. Cancer Res 64, 5672-5676 (2004) (Pubitemid 39095564)
44. M. H. Wu, T. M. Hong, H. W. Cheng, S. H. Pan, Y. R. Liang, H. C. Hong, W. F. Chiang, T. Y. Wong, D. B. Shieh, A. L. Shiau, Y. T. Jin, Y. L. Chen: Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res 7, 311-308 (2009)
45. M. V. Espelt, D. O. Croci, M. L. Bacigalupo, P. Carabias, M. Manzi, M. T. Elola, M. C. Munoz, F. P. Dominici, C. Wolfenstein-Todel, G. A. Rabinovich, M. F. Troncoso: Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization and in vivo tumor growth. HEPATOLOGY (2011) [Epub ahead of print]
46. M. E. Huflejt, H. Leffler: Galectin-4 in normal tissues and cancer. Glycoconj J 20(4), 247-255 (2004) (Pubitemid 39090671)
47. Y. Oda, J. Herrmann, M. A. Gitt, C. W. Turck, A. L. Burlingame, S. H. Barondes, H. Leffler: Soluble lactosebinding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem 268(8), 5929-5939 (1993) (Pubitemid 23090929)
48. M. L. Chiu, J. C. Jones, E. J. O'Keefe: Restricted tissue distribution of a 37-kD possible adherens junction protein. J Cell Biol 119(6), 1689-1700 (1992) (Pubitemid 23006565)
49. M. L. Chiu, D. A. Parry, S. R. Feldman, D. G. Klapper, E. J. O'Keefe: An adherens junction protein is a member of the family of lactose-binding lectins. J Biol Chem 269(50), 31770-31776 (1994) (Pubitemid 24379547)
50. E. M. Danielsen, G. H. Hansen: Lipid raft organization and function in the small intestinal brush border. J Physiol Biochem 64(4), 377-382 (2008)
51. D. Delacour, V. Gouyer, J. P. Zanetta, H. Drobecq, E. Leteurtre, G. Grard, O. Moreau-Hannedouche, E. Maes, A. Pons, S. Andre, A. Le Bivic, H. J. Gabius, A. Manninen, K. Simons, G. Huet: Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J Cell Biol 169(3), 491-501 (2005) (Pubitemid 40686699)
52. M. A. Wooters, S. L. Ropp, A. K. Erickson: Identification of galectin-4 isoforms in porcine small intestine. Biochimie 87(2), 143-149 (2005) (Pubitemid 40348993)
53. H. Ideo, A. Seko, K. Yamashita: Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 280(6), 4730-4737 (2005) (Pubitemid 40288643)
54. A. M. Wu, J. H. Wu, J. H. Liu, T. Singh, S. Andre, H. Kaltner, H. J. Gabius: Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galbeta1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 86(4-5), 317-326 (2004) (Pubitemid 38780838)
55. P. Sörme, B. Kahl-Knutsson, M. Huflejt, U. J. Nilsson, H. Leffler: Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal Biochem 334(1), 36-47 (2004) (Pubitemid 39304073)
56. H. Ideo, A. Seko, K. Yamashita: Recognition mechanism of galectin-4 for cholesterol 3-sulfate. J Biol Chem 282(29), 21081-21089 (2007) (Pubitemid 47099936)
57. A. Hokama, E. Mizoguchi, A. Mizoguchi: Roles of galectins in inflammatory bowel disease. World J Gastroenterol 14(33), 5133-5137 (2008)
58. E. Mizoguchi, A. Mizoguchi: Is the sugar always sweet in intestinal inflammation? Immunol Res 37(1), 47-60 (2007) (Pubitemid 46742283)
59. A. Hokama, E. Mizoguchi, K. Sugimoto, Y. Shimomura, Y. Tanaka, M. Yoshida, S. T. Rietdijk, Y. P. de Jong, S. B. Snapper, C. Terhorst, R. S. Blumberg, A. Mizoguchi: Induced reactivity of intestinal CD4 (+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20(6), 681-693 (2004) (Pubitemid 38757439)
60. A. Mathieu, N. Nagy, C. Decaestecker, L. Ferdinande, K. Vandenbroucke, P. Rottiers, C. A. Cuvelier, I. Salmon, P. Demetter: Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice. Int J Exp Pathol 89(6), 438-446 (2008)
61. D. Paclik, S. Danese, U. Berndt, B. Wiedenmann, A. Dignass, A. Sturm: Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PloS One 3(7), e2629 (2008)
62. D. Paclik, K. Lohse, B. Wiedenmann, A. U. Dignass, A. Sturm: Galectin-2 and -4, but not galectin-1, promote intestinal epithelial wound healing in vitro through a TGFbetaindependent mechanism. Inflamm Bowel Dis 14(10), 1366-1372 (2008)
63. H. Rechreche, G. V. Mallo, G. Montalto, J. C. Dagorn, J. L. Iovanna: Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. Eur J Biochem 248(1), 225-230 (1997) (Pubitemid 27356992)
64. S. Lee, S. Bang, K. Song, I. Lee: Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16(4), 747-754 (2006)
65. N. Nagy, H. Legendre, O. Engels, S. Andre, H. Kaltner, K. Wasano, Y. Zick, J. C. Pector, C. Decaestecker, H. J. Gabius, I. Salmon, R. Kiss: Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97(8), 1849-1858 (2003) (Pubitemid 36397258)
66. M. J. Scanlan, Y. T. Chen, B. Williamson, A. O. Gure, E. Stockert, J. D. Gordan, O. Tureci, U. Sahin, M. Pfreundschuh, L. J. Old: Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76(5), 652-658 (1998) (Pubitemid 28243936)
67. A. Satelli, P. S. Rao, S. Thirumala, U. S. Rao: Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer (2010) [Epub ahead of print]
68. M. Watanabe, I. Takemasa, N. Kaneko, Y. Yokoyama, E. I. Matsuo, S. Iwasa, M. Mori, N. Matsuura, M. Monden, O. Nishimura: Clinical significance of circulating galectins as colorectal cancer markers. Oncol Rep 25(5), 1217-1226 (2011)
69. N. Kondoh, T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi, N. Goseki, O. Matsubara, K. Takenaka, M. Shichita, K. Tanaka, M. Shuda, M. Yamamoto: Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59(19), 4990-4996 (1999) (Pubitemid 29472905)
70. Y. Hippo, M. Yashiro, M. Ishii, H. Taniguchi, S. Tsutsumi, K. Hirakawa, T. Kodama, H. Aburatani: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61(3), 889-895 (2001) (Pubitemid 32174397)
71. K. M. Rumilla, L. A. Erickson, A. K. Erickson, R. V. Lloyd: Galectin-4 expression in carcinoid tumors. Endoc Pathol 17(3), 243-249 (2006)
72. E. M. Duerr, Y. Mizukami, A. Ng, R. J. Xavier, H. Kikuchi, V. Deshpande, A. L. Warshaw, J. Glickman, M. H. Kulke, D. C. Chung: Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer 15(1), 243-256 (2008) (Pubitemid 351449743)
73. J. W. van Baal, F. Milano, A. M. Rygiel, J. J. Bergman, W. D. Rosmolen, S. J. van Deventer, K. K. Wang, M. P. Peppelenbosch, K. K. Krishnadath: A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129(4), 1274-1281 (2005) (Pubitemid 41446866)
74. C. Sakakura, K. Hasegawa, K. Miyagawa, S. Nakashima, T. Yoshikawa, S. Kin, Y. Nakase, S. Yazumi, H. Yamagishi, T. Okanoue, T. Chiba, A. Hagiwara: Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 11(18), 6479-6488 (2005) (Pubitemid 41338985)
75. D. Tripodi, S. Quemener, K. Renaudin, C. Ferron, O. Malard, I. Guisle-Marsollier, V. Sebille-Rivain, C. Verger, C. Geraut, C. Gratas-Rabbia-Re: Gene expression profiling in sinonasal adenocarcinoma. BMC Med Genom 2, 65 (2009)
76. V. A. Heinzelmann-Schwarz, M. Gardiner-Garden, S. M. Henshall, J. P. Scurry, R. A. Scolyer, A. N. Smith, A. Bali, P. Vanden Bergh, S. Baron-Hay, C. Scott, D. Fink, N. F. Hacker, R. L. Sutherland, P. M. O'Brien: A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br J Cancer 94(6), 904-913 (2006)
77. R. T. Marquez, K. A. Baggerly, A. P. Patterson, J. Liu, R. Broaddus, M. Frumovitz, E. N. Atkinson, D. I. Smith, L. Hartmann, D. Fishman, A. Berchuck, R. Whitaker, D. M. Gershenson, G. B. Mills, R. C. Bast, Jr., K. H. Lu: Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11(17), 6116-6126 (2005) (Pubitemid 41262937)
78. D. Houzelstein, I. R. Goncalves, A. J. Fadden, S. S. Sidhu, D. N. Cooper, K. Drickamer, H. Leffler, F. Poirier: Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 21(7), 1177-1187 (2004) (Pubitemid 38823721)
79. M. A. Gitt, C. Colnot, F. Poirier, K. J. Nani, S. H. Barondes, H. Leffler: Galectin-4 and galectin-6 are two closely related lectins expressed in mouse gastrointestinal tract. J Biol Chem 273(5), 2954-2960 (1998) (Pubitemid 28133947)
80. M. A. Gitt, Y. R. Xia, R. E. Atchison, A. J. Lusis, S. H. Barondes, H. Leffler: Sequence, structure, and chromosomal mapping of the mouse Lgals6 gene, encoding galectin-6. J Biol Chem 273(5), 2961-2970 (1998) (Pubitemid 28133948)
81. V. Markova, K. Smetana, Jr., G. Jenikova, J. Lachova, V. Krejcirikova, M. Poplstein, M. Fabry, J. Brynda, R. A. Alvarez, R. D. Cummings, P. Maly: Role of the carbohydrate recognition domains of mouse galectin-4 in oligosaccharide binding and epitope recognition and expression of galectin-4 and galectin-6 in mouse cells and tissues. Int J Mol Med 18(1), 65-76 (2006)
82. Y. R. Hadari, K. Paz, R. Dekel, T. Mestrovic, D. Accili, Y. Zick: Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 270(7), 3447-3453 (1995)
83. Z. Z. Su, J. Lin, R. Shen, P. E. Fisher, N. I. Goldstein, P. B. Fisher: Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Nat Acad Sci USA 93(14), 7252-7257 (1996) (Pubitemid 26243535)
84. L. Dazord, D. Bourel, A. Martin, R. Lecorre, P. Bourguet, J. Bohy, J. C. Saccavini, P. Delaval, M. Louvet, L. Toujas: A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice. Cancer Immunol Immunother 24, 263-268 (1987) (Pubitemid 17120717)
85. S. Henno, F. Brichory, T. Langanay, B. Desrues, N. Bidon, P. Delaval, M. P. Ramee, L. Dazord, S. Caulet-Maugendre: Expression of Po66-CBP, a galectin-8, in different types of primary and secondary bronchopulmonary tumors. Oncol Rep 9(1), 177-180 (2002)
86. N. Bidon-Wagner, J. P. Le Pennec: Human galectin-8 isoforms and cancer. Glycoconj J 19(7-9), 557-563 (2004) (Pubitemid 38316530)
87. H. Ahmed, P. P. Banerjee, G. R. Vasta: Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation. Biochem Biophys Res Commun 358(1), 241-246 (2007) (Pubitemid 46719109)
88. D. N. Cooper: Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572(2-3), 209-231 (2002) (Pubitemid 35246346)
89. N. Bidon, F. Brichory, S. Hanash, P. Bourguet, L. Dazord, J. P. Le Pennec: Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line. Gene 274(1-2), 253-262 (2001) (Pubitemid 32817143)
90. N. Nishi, A. Itoh, H. Shoji, H. Miyanaka, T. Nakamura: Galectin-8 and galectin-9 are novel substrates for thrombin. Glycobiology 16(11), 15C-20C (2006) (Pubitemid 44530694)
91. H. Ideo, A. Seko, I. Ishizuka, K. Yamashita: The Nterminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 13(10), 713-723 (2003) (Pubitemid 37337052)
92. H. Ideo, T. Matsuzaka, T. Nonaka, A. Seko, K. Yamashita: Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans. J Biol Chem 286(13), 11346-11355 (2011)
93. S. K. Patnaik, B. Potvin, S. Carlsson, D. Sturm, H. Leffler, P. Stanley: Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology 16(4), 305-317 (2006)
94. Y. Zick, M. Eisenstein, R. A. Goren, Y. R. Hadari, Y. Levy, D. Ronen: Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J 19(7-9), 517-526 (2004)
95. Y. R. Hadari, R. Arbel-Goren, Y. Levy, A. Amsterdam, R. Alon, R. Zakut, Y. Zick: Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113(Pt 13), 2385-2397 (2000) (Pubitemid 30599342)
96. Y. Levy, R. Arbel-Goren, Y. R. Hadari, S. Eshhar, D. Ronen, E. Elhanany, B. Geiger, Y. Zick: Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 276(33), 31285-31295 (2001) (Pubitemid 37384999)
97. Y. Levy, D. Ronen, A. D. Bershadsky, Y. Zick: Sustained induction of ERK, protein kinase B, and p70 S6 kinase regulates cell spreading and formation of F-actin microspikes upon ligation of integrins by galectin-8, a mammalian lectin. J Biol Chem 278(16), 14533-14542 (2003) (Pubitemid 36800007)
98. S. Diskin, Z. Cao, H. Leffler, N. Panjwani: The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology 19(1), 29-37 (2009)
99. L. Eshkar Sebban, D. Ronen, D. Levartovsky, O. Elkayam, D. Caspi, S. Aamar, H. Amital, A. Rubinow, I. Golan, D. Naor, Y. Zick: The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Biol Chem 179(2), 1225-1235 (2007)
100. E. Pardo, C. Carcamo, L. Massardo, V. Mezzano, S. Jacobelli, A. Gonzalez, A. Soza: Antibodies against galectin-8 in patients with systemic lupus erythematosus. Rev Méd Chile 134(2), 159-166 (2006) (Pubitemid 43429513)
101. M. D. Romero, J. C. Muiño, G. A Bianco, M. Ferrero, C. P. Juarez, J. D. Luna, G. A. Rabinovich: Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci 47(4), 1550-1556 (2006) (Pubitemid 46780764)
102. A. Norambuena, C. Metz, L. Vicuna, A. Silva, E. Pardo, C. Oyanadel, L. Massardo, A. Gonzalez, A. Soza: Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation. J Biol Chem 284(19), 12670-12679 (2009)
103. M. V. Tribulatti, J. Mucci, V. Cattaneo, F. Aguero, T. Gilmartin, S. R. Head, O. Campetella: Galectin-8 induces apoptosis in the CD4 (high) CD8 (high) thymocyte subpopulation. Glycobiology 17(12), 1404-1412 (2007) (Pubitemid 350131316)
104. M. V. Tribulatti, V. Cattaneo, U. Hellman, J. Mucci, O. Campetella: Galectin-8 provides costimulatory and proliferative signals to T lymphocytes. J Leukoc Biol 86(2), 371-380 (2009)
105. J. P. Cerliani, S. R. Stowell, I. D. Mascanfroni, C. M. Arthur, R. D. Cummings, G. A. Rabinovich: Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J Clin Immunol 31(1), 10-21 (2011)
106. H. Yamamoto, N. Nishi, H. Shoji, A. Itoh, L. H. Lu, M. Hirashima, T. Nakamura: Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T cells. J Biochem 143(3), 311-324 (2008) (Pubitemid 351363944)
107. N. Nishi, H. Shoji, M. Seki, A. Itoh, H. Miyanaka, K. Yuube, M. Hirashima, T. Nakamura: Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology 13(11), 755-763 (2003) (Pubitemid 37407105)
108. S. Caulet-Maugendre, S. Birolleau, H. Corbineau, R. Bassen, B. Desrues, N. Bidon, P. Delaval, M. P. Ramee, F. Brichory, L. Dazord: Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes. Pathol Res Pract 197(12), 797-801 (2001) (Pubitemid 34036974)
109. B. Desrues, F. Brichory, H. Lena, P. Bourguet, P. Delaval, L. Toujas, L. Dazord: Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicin. Cancer Immunol Immunother 43(5), 269-274 (1996)
110. N. Nagy, Y. Bronckart, I. Camby, H. Legendre, H. Lahm, H. Kaltner, Y. Hadari, P. Van Ham, P. Yeaton, J. C. Pector, Y. Zick, I. Salmon, A. Danguy, R. Kiss, H. J. Gabius: Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut 50(3), 392-401 (2002) (Pubitemid 34161058)
111. H. Lu, K. L. Knutson, E. Gad, M. L. Disis: The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens. Cancer Res 66(19), 9754-9761 (2006) (Pubitemid 44623677)
112. I. Camby, N. Belot, S. Rorive, F. Lefranc, C. A. Maurage, H. Lahm, H. Kaltner, Y. Hadari, M. M. Ruchoux, J. Brotchi, Y. Zick, I. Salmon, H. J. Gabius, R. Kiss: Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 11(1), 12-26 (2001)
113. G. W. Dong, J. Kim, J. H. Park, J. Y. Choi, S. I. Cho, S. C. Lim: Galectin-8 expression in laryngeal squamous cell carcinoma. Clin Exp Otorhinolaryngol 2(1), 13-19 (2009)
114. A. Danguy, S. Rorive, C. Decaestecker, Y. Bronckart, H. Kaltner, Y. R. Hadari, R. Goren, Y. Zich, M. Petein, I. Salmon, H. J. Gabius, R. Kiss: Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 16(3), 861-868 (2001) (Pubitemid 32700398)
115. L. N. Cueni, M. Detmar: Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp Cell Res 315(10), 1715-1723 (2009)
116. M. A. Romaniuk, M. V. Tribulatti, V. Cattaneo, M. J. Lapponi, F. C. Molinas, O. Campetella, M. Schattner. Human platelets express and are activated by galectin-8. Biochem J 432(3), 535-547 (2010)
117. N. Pacienza, R. G. Pozner, G. A. Bianco, P. D'Atri, D. O. Croci, S. Negrotto, E. Malaver, R. M. Gómez, G. A. Rabinovich, M. Schattner. The immunoregulatory glycanbinding protein galectin-1 triggers human platelet activation. FASEB J 22, 1113-1123 (2008) (Pubitemid 351519966)
118. S. H. Barondes, D. N. Cooper, M. A. Gitt, H. Leffler: Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269(33), 20807-20810 (1994)
119. J. Wada, K. Ota, A. Kumar, E. I. Wallner, Y. S. Kanwar: Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99(10), 2452-2461 (1997) (Pubitemid 27227724)
120. J. Wada, Y. S. Kanwar: Identification and characterization of galectin-9, a novel beta-galactosidebinding mammalian lectin. J Biol Chem 272(9), 6078-6086 (1997) (Pubitemid 27102450)
121. O. Türeci, H. Schmitt, N. Fadle, M. Pfreundschuh, U. Sahin: Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272(10), 6416-6422 (1997) (Pubitemid 27118120)
122. R. Matsumoto, H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, M. Hirashima: Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273(27), 16976-16984 (1998) (Pubitemid 28311730)
123. T. Imaizumi, M. Kumagai, N. Sasaki, H. Kurotaki, F. Mori, M. Seki, N. Nishi, K. Fujimoto, K. Tanji, T. Shibata, W. Tamo, T. Matsumiya, H. Yoshida, X. F. Cui, S. Takanashi, K. Hanada, K. Okumura, S. Yagihashi, K. Wakabayashi, T. Nakamura, M. Hirashima, K. Satoh: Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 72(3), 486-491 (2002)
124. I. Vega-Carrascal, E. P. Reeves, T. Niki, T. Arikawa, P. McNally, S. J. O'Neill, M. Hirashima, N. G. McElvaney: Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J Immunol 186(5), 2897-2909 (2011)
125. M. Sato, N. Nishi, H. Shoji, M. Seki, T. Hashidate, J. Hirabayashi, K. Kasai Ki, Y. Hata, S. Suzuki, M. Hirashima, T. Nakamura: Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 12(3), 191-197 (2002) (Pubitemid 34567865)
126. M. Nagae, N. Nishi, T. Murata, T. Usui, T. Nakamura, S. Wakatsuki, R. Kato: Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition. J Biol Chem 281(47), 35884-35893 (2006) (Pubitemid 46041320)
127. M. Nagae, N. Nishi, S. Nakamura-Tsuruta, J. Hirabayashi, S. Wakatsuki, R. Kato: Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J Mol Biol 375(1), 119-135 (2008) (Pubitemid 350160685)
128. M. Nagae, N. Nishi, T. Murata, T. Usui, T. Nakamura, S. Wakatsuki, R. Kato: Structural analysis of the recognition mechanism of poly-N- acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain. Glycobiology 19(2), 112-117 (2009)
129. S. Chabot, Y. Kashio, M. Seki, Y. Shirato, K. Nakamura, N. Nishi, T. Nakamura, R. Matsumoto, M. Hirashima: Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12(2), 111-118 (2002) (Pubitemid 34428934)
130. M. Hirashima, Y. Kashio, N. Nishi, A. Yamauchi, T. A. Imaizumi, T. Kageshita, N. Saita, T. Nakamura: Galectin-9 in physiological and pathological conditions. Glycoconj J 19(7-9), 593-600 (2004) (Pubitemid 38460942)
131. Y. Kashio, K. Nakamura, M. J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, M. Hirashima: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170(7), 3631-3636 (2003) (Pubitemid 36359232)
132. A. Sanchez-Fueyo, J. Tian, D. Picarella, C. Domenig, X. X. Zheng, C. A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V. K. Kuchroo, J. C. Gutierrez-Ramos, A. J. Coyle, T. B. Strom: Tim-3 inhibits T helper type
133. C. Zhu, A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, V. K. Kuchroo: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6(12), 1245-1252 (2005) (Pubitemid 43045636)
134. W. D. Hastings, D. E. Anderson, N. Kassam, K. Koguchi, E. A. Greenfield, S. C. Kent, X. X. Zheng, T. B. Strom, D. A. Hafler, V. K. Kuchroo: TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 39(9), 2492-2501 (2009)
135. F. C. Chou, S. J. Shieh, H. K. Sytwu: Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 39(9), 2403-2411 (2009)
136. A. C. Anderson, D. E. Anderson: TIM-3 in autoimmunity. Curr Opin Immunol 18(6), 665-669 (2006) (Pubitemid 44635179)
137. A. C. Anderson, D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, J. N. Bruce, L. P. Kane, V. K. Kuchroo, D. A. Hafler: Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318(5853), 1141-1143 (2007) (Pubitemid 350134897)
138. S. Y. Dai, R. Nakagawa, A. Itoh, H. Murakami, Y. Kashio, H. Abe, S. Katoh, K. Kontani, M. Kihara, S. L. Zhang, T. Hata, T. Nakamura, A. Yamauchi, M. Hirashima: Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 175(5), 2974-2981 (2005) (Pubitemid 41170515)
139. A. Matsuura, J. Tsukada, T. Mizobe, T. Higashi, F. Mouri, R. Tanikawa, A. Yamauchi, M. Hirashima, Y. Tanaka: Intracellular galectin-9 activates inflammatory cytokines in monocytes. Genes Cells 14(4), 511-521 (2009)
140. Y. Li, J. Feng, S. Geng, H. Wei, G. Chen, X. Li, L. Wang, R. Wang, H. Peng, G. Han, B. Shen: The N-and Cterminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity. Mol Immunol 48(4), 670-677 (2011)
141. E. W. Su, S. Bi, L. P. Kane: Galectin-9 regulates T helper cell function independently of Tim-3. Glycobiology (2010) [Epub ahead of print]
142. Matsumoto. M. Hirashima, H. Kita, G. J. Gleich: Biological activities of ecalectin: a novel eosinophilactivating factor. J Immunol 168(4), 1961-1967 (2002) (Pubitemid 34135799)
143. N. Saita, E. Goto, T. Yamamoto, I. Cho, K. Tsumori, H. Kohrogi, K. Maruo, T. Ono, M. Takeya, Y. Kashio, K. Nakamura, M. Hirashima: Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 128(1), 42-50 (2002) (Pubitemid 34621665)
144. H. Asakura, Y. Kashio, K. Nakamura, M. Seki, S. Dai, Y. Shirato, M. J. Abedin, N. Yoshida, N. Nishi, T. Imaizumi, N. Saita, Y. Toyama, H. Takashima, T. Nakamura, M. Ohkawa, M. Hirashima: Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 169(10), 5912-5918 (2002) (Pubitemid 35291697)
145. A. Fukushima, T. Sumi, K. Fukuda, N. Kumagai, T. Nishida, K. Okumura, H. Akiba, H. Yagita, H. Ueno: Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice. Int Arch Allergy Immunol 146(1), 36-43 (2008) (Pubitemid 351562941)
146. S. Katoh, N. Ishii, A. Nobumoto, K. Takeshita, S. Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, M. Hirashima: Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 176(1), 27-35 (2007) (Pubitemid 47048051)
147. T. Niki, S. Tsutsui, S. Hirose, S. Aradono, Y. Sugimoto, K. Takeshita, N. Nishi, M. Hirashima: Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 284(47), 32344-32352 (2009)
148. E. Sziksz, G. T. Kozma, E. Pallinger, Z. I. Komlosi, C. Adori, L. Kovacs, B. Szebeni, K. Rusai, G. Losonczy, A. Szabo, A. Vannay: Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. Int Arch Allergy Immunol 151(4), 308-317 (2010)
149. Y. Tsuchiyama, J. Wada, H. Zhang, Y. Morita, K. Hiragushi, K. Hida, K. Shikata, M. Yamamura, Y. S. Kanwar, H. Makino: Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int 58(5), 1941-1952 (2000)
150. M. Seki, K. M. Sakata, S. Oomizu, T. Arikawa, A. Sakata, M. Ueno, A. Nobumoto, T. Niki, N. Saita, K. Ito, S. Y. Dai, S. Katoh, N. Nishi, M. Tsukano, K. Ishikawa, A. Yamauchi, V. Kuchroo, M. Hirashima: Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 56(12), 3968-3976 (2007) (Pubitemid 350262324)
151. M. Seki, S. Oomizu, K. M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, N. Nishi, A. Yamauchi, S. Katoh, A. Matsukawa, V. Kuchroo, M. Hirashima: Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127(1), 78-88 (2008)
152. T. Arikawa, K. Watanabe, M. Seki, A. Matsukawa, S. Oomizu, K. M. Sakata, A. Sakata, M. Ueno, N. Saita, T. Niki, A. Yamauchi, M. Hirashima: Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Clin Immunol 133(3), 382-392 (2009)
153. K. Koguchi, D. E. Anderson, L. Yang, K. C. O'Connor, V. K. Kuchroo, D. A. Hafler: Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 203(6), 1413-1418 (2006) (Pubitemid 43877603)
154. Y. Wang, J. Meng, X. Wang, S. Liu, Q. Shu, L. Gao, Y. Ju, L. Zhang, W. Sun, C. Ma: Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 67(1), 63-70 (2008) (Pubitemid 350209587)
155. H. F. Pan, N. Zhang, W. X. Li, J. H. Tao, D. Q. Ye: TIM-3 as a new therapeutic target in systemic lupus erythematosus. Mol Biol Rep 37(1), 395-398 (2010)
156. H. Niwa, T. Satoh, Y. Matsushima, K. Hosoya, K. Saeki, T. Niki, M. Hirashima, H. Yokozeki: Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1-and/or Th17-mediated skin inflammation. Clin Immunol 132(2), 184-194 (2009)
157. Y. Uchida, B. Ke, M. C. Freitas, H. Yagita, H. Akiba, R. W. Busuttil, N. Najafian, J. W. Kupiec-Weglinski: Tcell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 139(6), 2195-2206 (2010)
158. K. Sakai, E. Kawata, E. Ashihara, Y. Nakagawa, A. Yamauchi, H. Yao, R. Nagao, R. Tanaka, A. Yokota, M. Takeuchi, H. Hirai, S. Kimura, M. Hirashima, N. Yoshimura, T. Maekawa: Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis. Eur J Immunol 41(1), 67-75 (2011)
159. Y. Tsuboi, H. Abe, R. Nakagawa, S. Oomizu, K. Watanabe, N. Nishi, T. Nakamura, A. Yamauchi, M. Hirashima: Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin Immunol 124(2), 221-233 (2007) (Pubitemid 47059041)
160. T. Arikawa, N. Saita, S. Oomizu, M. Ueno, A. Matsukawa, S. Katoh, K. Kojima, K. Nagahara, M. Miyake, A. Yamauchi, H. Kohrogi, M. Hirashima: Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol 40(2), 548-558 (2010)
161. P. Jayaraman, I. Sada-Ovalle, S. Beladi, A. C. Anderson, V. Dardalhon, C. Hotta, V. K. Kuchroo, S. M. Behar: Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 207(11), 2343-2354 (2010)
162. J. A. Mengshol, L. Golden-Mason, T. Arikawa, M. Smith, T. Niki, R. McWilliams, J. A. Randall, R. McMahan, M. A. Zimmerman, M. Rangachari, E. Dobrinskikh, P. Busson, S. J. Polyak, M. Hirashima, H. R. Rosen: A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PloS One 5(3), e9504 (2010)
163. S. Sehrawat, A. Suryawanshi, M. Hirashima, B. T. Rouse: Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol 182(5), 3191-3201 (2009)
164. S. Sehrawat, P. B. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, B. T. Rouse: Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog 6(5), e1000882 (2010)
165. K. Nagahara, T. Arikawa, S. Oomizu, K. Kontani, A. Nobumoto, H. Tateno, K. Watanabe, T. Niki, S. Katoh, M. Miyake, S. Nagahata, J. Hirabayashi, V. K. Kuchroo, A. Yamauchi, M. Hirashima: Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol 181(11), 7660-7669 (2008)
166. A. Nobumoto, S. Oomizu, T. Arikawa, S. Katoh, K. Nagahara, M. Miyake, N. Nishi, K. Takeshita, T. Niki, A. Yamauchi, M. Hirashima: Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin Immunol 130(3), 322-330 (2009)
167. A. Lee, J. M. Chick, D. Kolarich, P. A. Haynes, G. R. Robertson, M. Tsoli, L. Jankova, S. J. Clarke, N. H. Packer, M. S. Baker: Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumour. Mol Cell Proteomics (2010) [Epub ahead of print]
168. T. Kageshita, Y. Kashio, A. Yamauchi, M. Seki, M. J. Abedin, N. Nishi, H. Shoji, T. Nakamura, T. Ono, M. Hirashima: Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99(6), 809-816 (2002) (Pubitemid 34575697)
169. A. Kasamatsu, K. Uzawa, D. Nakashima, H. Koike, M. Shiiba, H. Bukawa, H. Yokoe, H. Tanzawa: Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 16(2), 269-273 (2005)
170. M. Liang, M. Ueno, S. Oomizu, T. Arikawa, R. Shinonaga, S. Zhang, A. Yamauchi, M. Hirashima: Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol 134(8), 899-907 (2008)
171. A. Irie, A. Yamauchi, K. Kontani, M. Kihara, D. Liu, Y. Shirato, M. Seki, N. Nishi, T. Nakamura, H. Yokomise, M. Hirashima: Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res 11(8), 2962-2968 (2005) (Pubitemid 40525199)
172. A. Yamauchi, K. Kontani, M. Kihara, N. Nishi, H. Yokomise, M. Hirashima: Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer. Breast J 12(5 Suppl 2), S196-200 (2006) (Pubitemid 44337468)
173. A. Nobumoto, K. Nagahara, S. Oomizu, S. Katoh, N. Nishi, K. Takeshita, T. Niki, A. Tominaga, A. Yamauchi, M. Hirashima: Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology 18(9), 735-744 (2008)
174. F. Zhang, M. Zheng, Y. Qu, J. Li, J. Ji, B. Feng, A. Lu, M. Wang, B. Liu: Different roles of galectin-9 isoforms in modulating E-selectin expression and adhesion function in LoVo colon carcinoma cells. Mol Biol Rep 36(5), 823-830 (2009)
175. S. Makishi, T. Okudaira, C. Ishikawa, S. Sawada, T. Watanabe, M. Hirashima, H. Sunakawa, N. Mori: A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells. Br J Haematol 142(4), 583-594 (2008) (Pubitemid 352020212)
176. L. H. Lu, R. Nakagawa, Y. Kashio, A. Ito, H. Shoji, N. Nishi, M. Hirashima, A. Yamauchi, T. Nakamura: Characterization of galectin-9-induced death of Jurkat T cells. J Biochem 141(2), 157-172 (2007) (Pubitemid 46775753)
177. J. Kuroda, M. Yamamoto, H. Nagoshi, T. Kobayashi, N. Sasaki, Y. Shimura, S. Horiike, S. Kimura, A. Yamauchi, M. Hirashima, M. Taniwaki: Targeting activating transcription factor 3 by Galectin-9 induces apoptosis and overcomes various types of treatment resistance in chronic myelogenous leukemia. Mol Cancer Res 8(7), 994-1001 (2010)
178. T. Kobayashi, J. Kuroda, E. Ashihara, S. Oomizu, Y. Terui, A. Taniyama, S. Adachi, T. Takagi, M. Yamamoto, N. Sasaki, S. Horiike, K. Hatake, A. Yamauchi, M. Hirashima, M. Taniwaki: Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways. Leukemia 24(4), 843-850 (2010)
179. R. Y. Yang, D. K. Hsu, L. Yu, J. Ni, F. T. Liu: Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 276(23), 20252-20260 (2001)
180. K. Hotta, T. Funahashi, Y. Matsukawa, M. Takahashi, H. Nishizawa, K. Kishida, M. Matsuda, H. Kuriyama, S. Kihara, T. Nakamura, Y. Tochino, N. L. Bodkin, B. C. Hansen, Y. Matsuzawa: Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity. J Biol Chem 276(36), 34089-34097 (2001)
181. M. Fasshauer, J. Klein, U. Lossner, R. Paschke: Negative regulation of adipose-expressed galectin-12 by isoproterenol, tumor necrosis factor alpha, insulin and dexamethasone. Eur J Endocrinol 147(4), 553-559 (2002) (Pubitemid 35238151)
182. R. Y. Yang, D. K. Hsu, L. Yu, H. Y. Chen, F. T. Liu: Galectin-12 is required for adipogenic signaling and adipocyte differentiation. J Biol Chem 279(28), 29761-29766 (2004) (Pubitemid 38915859)
183. M. A. Toscano, J. M. Ilarregui, G. A. Bianco, L. Campagna, D. O. Croci, M. Salatino, G. A. Rabinovich: Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity? Cytokine Growth Factor Rev 18(1-2), 57-71 (2007) (Pubitemid 46401430)
184. M. A. Toscano, J. M. Ilarregui, G. A. Bianco, N. Rubinstein, G. A. Rabinovich: How do protein-glycan interactions regulate T-cell physiology? Medicina (B Aires) 66(4), 357-362 (2006) (Pubitemid 44390053)
185. E. Ciliberti, L. Carambia, S. Cavallin, O. L. Cerda, J. J. Poderoso, G. A. Rabinovich: Tolerance and autoimmunity. Novel therapeutic approaches. Medicina (B Aires) 69(4), 460-465 (2009)
186. D. O. Croci, M. F. Zacarías Fluck, M. J. Rico, P. Matar, G. A. Rabinovich, O. G. Scharovsky: Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment. Cancer Immunol Immunother 56(11), 1687-1700 (2007) (Pubitemid 47313090)